← All trials
NCT05148871
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2021
- Primary completion
- Jul 31, 2022
- Completion date
- Dec 31, 2022
- First posted
- Dec 8, 2021
- Last posted
- Dec 8, 2021
- Enrollment
- 2000
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vaxine Pty LtdLead sponsor
- CinnagenCollaborator
- Australian Respiratory and Sleep Medicine InstituteOverall official - principal investigator
- Australian Respiratory and Sleep Medicine InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.